#immunogenicity — Thursday, April 09, 2026 (2 items)
| 0 | ℹ |
Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial).
(bmj.com)
|
BMJ 2026-04-09 | #infection #vaccination #immunity #immunogenicity #tb | |
| 0 | ℹ |
Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.
(nejm.org)
|
New England Journal of Medicine 2026-04-09 | #vaccination #antibody #immunogenicity #safety #yellow fever |